touchPANEL DISCUSSION for touchNEUROLOGY
Listen to a panel of leading multiple sclerosis (MS) experts discuss their perspectives on the benefits of disease-modifying therapies (DMTs) in MS, and current approaches to treatment sequencing.
The experts
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/treatment-sequencing-in-ms-the-benefits-of-dmts/
CSCC treatment: Systemic therapy
CSCC treatment: Surgery or radiotherapy
Diagnostic workup in CSCC
Multidisciplinary care for CSCC
CSCC treatment: Systemic therapy
CSCC treatment: Surgery or radiotherapy
Diagnostic workup in CSCC
Multidisciplinary care and quality of life of adolescents/adults with SMA
Support structures for adolescents with SMA transitioning to the adult healthcare system
Later-onset SMA: Presentation and differential diagnosis
Multidisciplinary care and quality of life of adolescents/adults with SMA
Support structures for adolescents with SMA transitioning to the adult healthcare system
Later-onset SMA: Presentation and differential diagnosis
Personalized treatment of RET-altered thyroid cancers
Personalized treatment of RET-altered thyroid cancers
Focus on cognitive impairment in the diagnosis and management of relapsing MS – Part 3
Focus on cognitive impairment in the diagnosis and management of relapsing MS - Part 2
Focus on cognitive impairment in the diagnosis and management of relapsing MS - Part 1
MDT and patient perspectives on the importance of treatment intensification, weight loss, and education in T2D and obesity
MDT and patient perspectives on GLP-1 RA therapy and emerging incretin-based dual agonists in T2D and obesity
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
The Psychic Elephant Radio Podcast
Museum of the Missing
Sasquatch Chronicles
Hidden Brain